← Back to Discover
Davern Capital Partners, LP
Period ended Sep 30, 2026 · Latest filing Nov 12, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $514,064,996
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- BIONTECH SE · SPONSORED ADS · 09075V102 · shares: $67,055,148
- ROYALTY PHARMA PLC · SHS CLASS A · G7709Q104 · shares: $56,866,684
- INSMED INC · COM PAR $.01 · 457669307 · shares: $56,618,805
- ROIVANT SCIENCES LTD · SHS · G76279101 · shares: $53,860,589
- IONIS PHARMACEUTICALS INC · COM · 462222100 · shares: $48,540,890
- ARGENX SE · SPONSORED ADR · 04016X101 · shares: $36,052,139
- REGENERON PHARMACEUTICALS · COM · 75886F107 · shares: $30,832,016
- NATERA INC · COM · 632307104 · shares: $26,121,192
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $21,703,501
- VERA THERAPEUTICS INC · CL A · 92337R101 · shares: $20,286,967
Reported holdings
17 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| BIONTECH SE | SPONSORED ADS | 09075V102 | — | 682,148 shares | $67,055,148 |
| ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | — | 974,412 shares | $56,866,684 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 496,047 shares | $56,618,805 |
| ROIVANT SCIENCES LTD | SHS | G76279101 | — | 1,472,808 shares | $53,860,589 |
| IONIS PHARMACEUTICALS INC | COM | 462222100 | — | 1,087,142 shares | $48,540,890 |
| ARGENX SE | SPONSORED ADR | 04016X101 | — | 37,597 shares | $36,052,139 |
| REGENERON PHARMACEUTICALS | COM | 75886F107 | — | 40,661 shares | $30,832,016 |
| NATERA INC | COM | 632307104 | — | 63,200 shares | $26,121,192 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 219,183 shares | $21,703,501 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 628,274 shares | $20,286,967 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 695,152 shares | $17,469,170 |
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | — | 828,880 shares | $16,486,423 |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | — | 229,300 shares | $15,007,685 |
| ELI LILLY & CO | COM | 532457108 | — | 12,600 shares | $14,579,208 |
| GENERATE BIOMEDICINES INC | COM SHS | 370920100 | — | 824,679 shares | $12,386,679 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 560,710 shares | $11,545,019 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 564,441 shares | $8,652,881 |